Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry

Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry (ISACS CARDIONCO-PREDICT)

This study is being done in order to assess the cardiovascular events known as cardiovascular toxicity of chemotherapy agents and radiotherapy protocols in cancer subjects to identify risk prediction, prevention and treatment of cancer therapy-related cardiovascular toxicity and cancer therapy-related cardiac dysfunction

Inclusion Criteria:

• Age 18 years old or older
• Capable of giving informed consent
• Diagnosis of cancer scheduled for treatment according to treating physician's discretion
• Life expectancy >1 year
• For the prospective validation of HFA-ICOS risk score validation: Newly diagnosed breast cancer undergoing treatment with anthracyclines analogues with or without radiotherapy, with or without trastuzumab, or other anticancer drugs

Exclusion Criteria:

• Age <18 years old
• Not able to give informed consent
• Life expectancy <1 year
• Advanced-stage cancer not eligible for treatment (subjects with an indication of palliative care) according to treating physician's